EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Non-alcoholic fatty pancreas disease (NAFPD) as a pre-neoplastic niche: Metabolic and inflammatory Gateways to pancreatic ductal adenocarcinoma

Hope Onohuean, Ngozi F Nnolum-Orji, Sarad Pawar Naik Bukke, Kasim Sakran Abass, Abdullateef Isiaka Alagbonsi, Yahya E Choonara

Journal of Clinical & Translational Endocrinology · 2025-12 · 42 · 100424

DOI: 10.1016/j.jcte.2025.100424 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical & Translational Endocrinology, 2025-12. Verfasst von Hope Onohuean und 5 weiteren Autor:innen. Beteiligte Einrichtung: Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Scienc…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic fatty pancreas disease (NAFPD), marked by ectopic triglyceride accumulation in the exocrine pancreas, is increasingly observed yet its recognition as a cancer-predisposing condition remains limited. We synthesize evidence supporting NAFPD as an early and modifiable niche for pancreatic ductal adenocarcinoma (PDAC), using a PRISMA-ScR-guided framework. The findings were synthesized into three domains: epidemiological risk, metabolic-inflammatory signaling, and immune-stromal remodeling. Mechanisms include palmitate-induced ER stress, ROS-driven NLRP3-IL-1β and STAT5 signaling, and KRAS^G12D-mediated lipotoxicity. Lipid-laden stellate cells promote fibrosis, immunosuppression, and epithelial-mesenchymal transition. NAFPD may represent an early, modifiable PDAC niche, warranting further imaging-omic studies and targeted prevention trials.

Schlagwörter

Stichwörter der Autor:innen

Fatty pancreas diseaseInflammatoryMetabolicNon-alcoholicPancreatic ductal adenocarcinomaPre-neoplastic

Autor:innen und Institutionen

  • Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesbu…
  • Biomolecules, Metagenomics, Endocrine and Tropical Disease Research Group (BMETDREG), Kampala International University, Western Campus, Ishaka-Bushenyi, Uganda.
  • Biopharmaceutics Unit, Department of Pharmacology and Toxicology, School of Pharmacy, Kampala International University, Uganda.
  • Department of Pharmaceutics and Pharmaceutical Technology, Kampala International University, Western Campus, P.O. Box 71, Ishaka-Bushenyi, Uganda.
  • Department of Physiology, Biochemistry, and Pharmacology, Biochemistry, and Pharmacology, College of Veterinary Medicine, University of Kirkuk, Kirkuk 36001, Iraq.
  • Department of Physiology, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Huye, Rwanda.

Förderung

  • National Research Foundation

Zitieren

APA

Onohuean, H., Nnolum-Orji, N. F., Naik Bukke, S. P., Abass, K. S., Alagbonsi, A. I., & Choonara, Y. E. (2025). Non-alcoholic fatty pancreas disease (NAFPD) as a pre-neoplastic niche: Metabolic and inflammatory Gateways to pancreatic ductal adenocarcinoma. Journal of Clinical & Translational Endocrinology, 42, 100424. https://doi.org/10.1016/j.jcte.2025.100424

Vancouver

Onohuean H, Nnolum-Orji NF, Naik Bukke SP, Abass KS, Alagbonsi AI, Choonara YE. Non-alcoholic fatty pancreas disease (NAFPD) as a pre-neoplastic niche: Metabolic and inflammatory Gateways to pancreatic ductal adenocarcinoma. Journal of Clinical & Translational Endocrinology. 2025;42:100424. doi:10.1016/j.jcte.2025.100424

BibTeX
@article{Onohuean2025,
  author = {Onohuean, Hope and Nnolum-Orji, Ngozi F and Naik Bukke, Sarad Pawar and Abass, Kasim Sakran and Alagbonsi, Abdullateef Isiaka and Choonara, Yahya E},
  title = {Non-alcoholic fatty pancreas disease (NAFPD) as a pre-neoplastic niche: Metabolic and inflammatory Gateways to pancreatic ductal adenocarcinoma},
  journal = {Journal of Clinical & Translational Endocrinology},
  year = {2025},
  volume = {42},
  pages = {100424},
  doi = {10.1016/j.jcte.2025.100424}
}
Kostenlos starten →